TRANSCEND-T2D-1 Results by Dose (40 Weeks) The 16.8% weight loss in this population is substantially below TRIUMPH-1's 28.3% a pattern consistent across the GLP-1 drug class, where type 2 diabetes reduces the magnitude of weight loss compared to non-diabetic obesity populations
Semaglutide works by: Stimulates insulin production in the pancreas Reduces sugar production in the liver Slows down digestion, so food stays in the stomach longer Decreases appetite and food intake These combined actions help you feel full longer, eat less, and maintain better control over blood sugar levels
"Manufacturing Excellence in Peptide API Production: Quality Systems and Process Optimization." Industrial Pharmacy International, 2023
If you successfully managed constipation on another GLP-1 medication, those same strategies should work for Retatrutide
Youll also receive guidance around nutrition, movement, and lifestyleso medication is part of a broader, sustainable approach